Table 1. Expression of CD71 and IL-2R... | American Society of Hematology

Table 1.

Expression of CD71 and IL-2R Chains on Monocytes, B Lymphocytes, and NK Cells

Cell Type	Anticoagulant/Time	Percentage of Positive Cells
		CD71	IL-2 Receptor
		CD71	α	β	γ
Monocytes	Hep Na (d = 0)	6.6 ± 5.1	2.3 ± 3.1	4.5 ± 5.2	38 ± 23
	CPD (d = 0)	1.5 ± 1.4	24 ± 16*	32 ± 2.8†	61 ± 19
	ACD (d = 0)	6.9 ± 1.4	57 ± 19†	74 ± 9.5†	60 ± 23
	Hep Na (d = 1)	5.3 ± 5.5	6.4 ± 3.6‡	16 ± 4.8§	71 ± 15‡
B lymphocytes	Hep Na (d = 0)	2.1 ± 1.5	0.93 ± 1.3	0.55 ± 1.1	0.81 ± 1.3
	CPD (d = 0)	1.1 ± 1.5	4.1 ± 1.4§	7.5 ± 5.9§	5.2 ± 2.0*
	ACD (d = 0)	3.9 ± 3.4	14 ± 4.8†	24 ± 13†	10 ± 5.4*
	Hep Na (d = 1)	7.6 ± 1.5†	5.5 ± 0.69†	16 ± 12*	11 ± 9.1§
NK cells	Hep Na (d = 0)	1.8 ± 1.2	1.5 ± 1.3	76 ± 11	2.9 ± 1.8
	CPD (d = 0)	0.12 ± 0.21	0.61 ± 0.85	83 ± 6.6	0.71 ± 0.11
	ACD (d = 0)	0.11 ± 0.12	0.33 ± 0.58	70 ± 12	0.13 ± 0.16
	Hep Na (d = 1)	2.7 ± 2.4	1.6 ± 1.1	81 ± 17	4.3 ± 2.2

Cell Type	Anticoagulant/Time	Percentage of Positive Cells
		CD71	IL-2 Receptor
		CD71	α	β	γ
Monocytes	Hep Na (d = 0)	6.6 ± 5.1	2.3 ± 3.1	4.5 ± 5.2	38 ± 23
	CPD (d = 0)	1.5 ± 1.4	24 ± 16*	32 ± 2.8†	61 ± 19
	ACD (d = 0)	6.9 ± 1.4	57 ± 19†	74 ± 9.5†	60 ± 23
	Hep Na (d = 1)	5.3 ± 5.5	6.4 ± 3.6‡	16 ± 4.8§	71 ± 15‡
B lymphocytes	Hep Na (d = 0)	2.1 ± 1.5	0.93 ± 1.3	0.55 ± 1.1	0.81 ± 1.3
	CPD (d = 0)	1.1 ± 1.5	4.1 ± 1.4§	7.5 ± 5.9§	5.2 ± 2.0*
	ACD (d = 0)	3.9 ± 3.4	14 ± 4.8†	24 ± 13†	10 ± 5.4*
	Hep Na (d = 1)	7.6 ± 1.5†	5.5 ± 0.69†	16 ± 12*	11 ± 9.1§
NK cells	Hep Na (d = 0)	1.8 ± 1.2	1.5 ± 1.3	76 ± 11	2.9 ± 1.8
	CPD (d = 0)	0.12 ± 0.21	0.61 ± 0.85	83 ± 6.6	0.71 ± 0.11
	ACD (d = 0)	0.11 ± 0.12	0.33 ± 0.58	70 ± 12	0.13 ± 0.16
	Hep Na (d = 1)	2.7 ± 2.4	1.6 ± 1.1	81 ± 17	4.3 ± 2.2

Staining and analysis of these PBMC subsets have been performed as in Figs 1-3.

.0001 < P ≤ .001.

P ≤ .0001.

.01 < P < .05.

.001 < P ≤ .01.